Rock Creek Group, LP Galmed Pharmaceuticals Ltd. Transaction History

Rock Creek Group, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$3.22 - $6.08 $304,141 - $574,280	-94,454 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.3 - $6.84 $29,498 - $61,142	8,939 Added 10.45%	94,454 $327,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $6.75 $106,115 - $198,416	29,395 Added 52.38%	85,515 $494,000
Q3 2019 Nov 13, 2019	SELL	$4.62 - $7.11 $4,994 - $7,685	-1,081 Reduced 1.89%	56,120 $268,000
Q2 2019 Aug 14, 2019	BUY	$5.68 - $8.68 $324,901 - $496,504	57,201 New	57,201 $420,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.53M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.